SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
0 hedge funds and large institutions have $0 invested in SQZ Biotechnologies Company in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $333K → $0 (-$333K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIG
American International Group
New York
|
-$202K |
| 2 |
AG
Artal Group
Luxembourg
|
-$129K |
| 3 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
-$1K |
| 4 |
BSB
Bangor Savings Bank
Bangor,
Maine
|
-$911 |
| 5 |
Barclays
London,
United Kingdom
|
-$144 |
SQZ Hedge Fund Activity: Q4 2023 in Review
0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q4 2023, worth a combined $0 — down 100% from $333K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SQZ and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was American International Group, exiting entirely with an estimated $202K sold.
- 0 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q4 2023, down from 5 in Q3 2023.
- Funds reported $0 of SQZ Biotechnologies Company stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new SQZ Biotechnologies Company positions in Q4 2023 and 5 closed out, a net change of -5 holders.
- The largest SQZ Biotechnologies Company seller in Q4 2023 was American International Group, an estimated $202K sold.
Based on aggregated 13F filings for Q4 2023.